Parasite-specific IgM plays a significant role in the protective immune response to asexual erythrocytic stage Plasmodium chabaudi AS infection

Parasite Immunology

Volumn 27, Issue 5, 2005, Pages 171-180

  Couper, K N ^a,d   Phillips, R S ^b   Brombacher, F ^c   Alexander, J ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

IgM; Knockout mice; Plasmodium chabaudi

Indexed keywords

IMMUNOGLOBULIN D; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; ASEXUAL REPRODUCTION; B LYMPHOCYTE; CELL DIVISION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; ERYTHROCYTE; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MALE; MORTALITY; MOUSE; NONHUMAN; OPSONIZATION; PARASITEMIA; PARASITOSIS; PHAGOCYTOSIS; PLASMODIUM CHABAUDI; PRIORITY JOURNAL; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ERYTHROCYTES; IMMUNE SERA; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN M; MALARIA; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PARASITEMIA; PLASMODIUM CHABAUDI;

PLASMODIUM CHABAUDI;

EID: 22044440283     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2005.00760.x     Document Type: Article

References (44)

1. Mohan K, Moulin P & Stevenson MM. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J Immunol 1997; 159 (10): 4990-4998.
2. Stevenson MM, Huang DY, Podoba JE & Nowotarski ME. Macrophage activation during Plasmodium chabaudi AS infection in resistant C57BL/6 and susceptible A/J mice. Infect Immun 1992; 60 (3): 1193-1201.
3. + T cells to Plasmodium chabaudi chabaudi. Immunol Rev 1989; 112: 71-94.
4. + T cells reactive with Plasmodium chabaudi chabaudi: distinct response kinetics for cells with ThI and Th2 characteristics during infection. Int Immunol 1989; 1 (4): 416-424.
5. Taylor-Robinson AW, Phillips RS, Severn A, Moncada S & Liew FY. The role of TH1 and TH2 cells in a rodent malaria infection. Science 1993; 260 (5116): 1931-1934.
6. Taylor-Robinson AW & Phillips RS. B cells are required for the switch from Th1- to Th2-regulated immune responses to Plasmodium chabaudi chabaudi infection. Infect Immun 1994; 62 (6): 2490-2498.
7. + T cell subsets to Plasmodium chabaudi chabaudi in B cell-deficient mice. Int Immunol 1993; 5: 10: 1343-1348.
8. Cox J, Semoff S & Hommel M. Plasmodium chabaudi: a rodent malaria model for in vivo and in vitro cytoadherence of malaria parasites in the absence of knobs. Parasite Immunol 1987; 9 (5): 543-561.
9. + T-cell clones reactive to the murine malaria parasite Plasmodium chabaudi. Immunology 1992; 77 (1): 99-105.
10. Taylor-Robinson AW & Phillips RS. Reconstitution of B-cell-depleted mice with B cells restores Th2-type immune responses during Plasmodium chabaudi chabaudi infection. Infect Immun 1996; 64 (1): 366-370.
11. Seixas EM & Langhorne J. Gammadelta T cells contribute to control of chronic parasitemia in Plasmodium chabaudi infections in mice. J Immunol 1999; 162 (5): 2837-2841.
12. Weidanz WP, Kemp JR, Batchelder JM, Cigel FK, Sandor M & Heyde HC. Plasticity of immune responses suppressing parasitemia during acute Plasmodium chabaudi malaria. J Immunol 1999; 162 (12): 7383-7388.
13. Cohen S & Butcher GA. Serum antibody in acquired malarial immunity. Trans R Soc Trop Med Hyg 1971; 65 (2): 125-135.
14. Druilhe P & Khusmith S. Epidemiological correlation between levels of antibodies promoting merozoite phagocytosis of Plasmodium falciparum and malaria-immune status. Infect Immun 1987; 55 (4): 888-891.
15. Udeinya IJ, Miller LH, McGregor IA & Jensen JB. Plasmodium falciparum strain-specific antibody blocks binding of infected erythrocytes to amelanotic melanoma cells. Nature 1983; 303 (5916): 429-431.
16. Mota MM, Brown KN, Holder AA & Jarra W. Acute Plasmodium chabaudi chabaudi malaria infection induces antibodies which bind to the surfaces of parasitized erythrocytes and promote their phagocytosis by macrophages in vitro. Infect Immun 1998; 66 (9): 4080-4086.
17. Waki S. Antibody-dependent neutrophil-mediated parasite killing in non-lethal rodent malaria. Parasite Immunol 1994; 16 (11): 587-591.
18. Falanga PB, Franco da Silveira JF & Pereira da Silva L. Protective immune response to Plasmodium chabaudi, developed by mice after drug-controlled infection or vaccination with parasite extracts: analysis of stage specific antigens from the asexual blood cycle. Parasite Immunol 1984; 6 (6): 529-543.
19. McLean SA, Pearson CD & Phillips RS. Plasmodium chabaudi: antigenic variation during recrudescent parasitaemias in mice. Exp Parasitol 1982; 54 (3): 296-302.
20. Diggs CL, Hines F & Wellde BT. Plasmodium falciparum; passive immunization of Aotus lemurinus griseimembra with immune serum. Exp Parasitol 1995; 80 (2): 291-296.
21. Egan AF, Morris J, Barnish G, et al. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis 1996; 173 (3): 765-769.
22. O'Donnell RA, de Koning-Ward TF, Burt RA, et al. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria. J Exp Med 2001; 193 (12): 1403-1412.
23. Al-Yaman F, Genton B, Anders RF, et al Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea. Am J Trop Med Hyg 1994; 51 (5): 593-602.
24. Celada A, Cruchaud A & Perrin LH. Opsonic activity of human immune serum on in vitro phagocytosis of Plasmodium falciparum infected red blood cells by monocytes. Clin Exp Immunol 1982; 47 (3): 635-644.
25. Marsh K, Otoo L, Hayes RJ, Carson DC & Greenwood BM. Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg 1989; 83 (3): 293-303.
26. Cooper NR. The classical complement pathway: activation and regulation of the first complement component. Adv Immunol 1985; 37: 151-216.
27. Tao TW & Uhr JW. Primary-type antibody response in vitro. Science 1966; 151 (714): 1096-1098.
28. Kantor AB & Herzenberg LA. Origin of murine B cell lineages. Ann Rev Immunol 1993; 11: 501-538.
29. Ochsenbein AF, Fehr T, Lutz C, et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999; 286 (5447): 2156-2159.
30. Boes M, Prodeus AP, Schmidt T, Carroll MC & Chen J. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998; 188 (12): 2381-2386.
31. Yoder BJ & Goodrum KJ. Plasmodium chabaudi chabaudi: B-1 cell expansion correlates with semiresistance in BALB/cJ mice. Exp Parasitol 2001; 98 (2): 71-82.
32. Lutz C, Ledermann B, Kosco-Vilbois MH, et al. IgD can largely substitute for loss of IgM function in B cells. Nature 1998; 393 (6698): 797-801.
33. Trager W & Jenson JB. Cultivation of malarial parasites. Nature 1978; 273 (5664): 621-622.
34. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anals Biochem 1976; 72: 248-254.
35. Zhang W, Liu XQ, Xu H & Good MF. Polyspecific malaria antibodies present at the time of infection inhibit the development of immunity to malaria but antibodies specific for the malaria merozoite surface protein, MSP1, facilitate immunity. Parasite Immunol 2002; 24 (5): 233-241.
36. Rotman HL, Daly TM, Clynes R & Long CA. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model. J Immunol 1998; 161 (4): 1908-1912.
37. Vukovic P, Hogarth PM, Barnes N, Kaslow DC & Good MF. Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-gammaRI receptors. Infect Immun 2000; 68 (5): 3019-3022.
38. Stevenson MM & Ghadirian E. Human recombinant tumor necrosis factor alpha protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection. Infect Immun 1989; 57 (12): 3636-3639.
39. Taylor-Robinson AW. Increased production of acute-phase proteins corresponds to the peak parasitaemia of primary malaria infection. Parasitol Int 2000; 48 (4): 297-301.
40. Balmer P, McMonagle F, Alexander J & Phillips RS. Experimental erythrocytic malaria infection induces elevated serum amyloid P production in mice. Immunol Lett 2000; 72 (3): 147-152.
41. Steel DM & Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15 (2): 81-88.
42. Baumann H & Gauldie J. The acute phase response. Immunol Today 1994; 15 (2): 74-80.
43. White WI, Evans CB & Taylor DW. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii. Infect Immun 1991; 59 (10): 3547-3554.
44. Su Z & Stevenson MM. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J Immunol 2002; 168: 1348-1355.